Cyproheptadine Hydrochloride Tablet
Product Images NDC 0115-1757

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyproheptadine Hydrochloride (NDC 0115-1757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cyproheptadine Hydrochloride Tablets 1)

Chemical structure diagram of Cyproheptadine Hydrochloride showing the arrangement of benzene rings and the piperidine ring with a methyl substitution, alongside the hydrochloride (HCl) component.*

FDA Label Image

1 (Cyproheptadine Hydrochloride Tablets 2)

Cyproheptadine Hydrochloride Tablets USP 4 mg label by Amneal Pharmaceuticals. The label indicates oral tablets with 4 mg strength, a package count of 100 tablets, and includes storage instructions at 20° to 25°C. It shows manufacturing details for Amneal Pharmaceuticals Pvt. Ltd. in India and distribution by Amneal Pharmaceuticals LLC in New Jersey, USA. The label also contains a barcode and NDC 0115-1757-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.